日期 | 时间 | 会场 | Session | 角色 | 讲题 |
---|---|---|---|---|---|
2024-03-29 | 16:20-16:25 | 多功能厅B3 |
肿瘤及病理-大会发言(一) |
讲者 | Bevacizumab combined with chemotherapy is superior to chemotherapy in ovarian cancer after PARPi: evidence from a multi-centered propensity score-matched analysis |